Literature DB >> 19121765

Insulin resistance in chronic uremia.

Gianfranco Guarnieri1, Michela Zanetti, Pierandrea Vinci, Maria Rosa Cattin, Rocco Barazzoni.   

Abstract

Insulin resistance often characterizes chronic uremia, and is associated with enhanced morbidity and mortality, because it may contribute to protein-energy wasting (in turn, an independent predictor of reduced survival), atherosclerosis, and cardiovascular death. Causes of insulin resistance in chronic uremia are complex and multifactorial. Obesity is emerging as an independent risk factor for chronic kidney disease, and an expected rise in number of obese uremic patients because of the ongoing worldwide obesity epidemic is likely to increase the prevalence of insulin resistance in chronic uremia in the near future. Similar to the general population, reported associations between obesity and insulin resistance in chronic uremia support a role of adipose tissue and altered adipokine profiles in insulin resistance in obese chronic kidney disease patients. Hormonal imbalances, chronic acidosis, and systemic inflammation and oxidative stress are uremia-associated relevant causes of insulin resistance in nonobese individuals. A further understanding of the causes of insulin resistance in chronic uremia represents a potential important tool in the design of more effective therapeutic strategies to reduce uremia-associated morbidity and mortality.

Entities:  

Mesh:

Year:  2009        PMID: 19121765     DOI: 10.1053/j.jrn.2008.11.014

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  19 in total

1.  Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation.

Authors:  Jinling Hou; Zhao Zhong Chong; Yan Chen Shang; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2010-05       Impact factor: 1.990

2.  EPO relies upon novel signaling of Wnt1 that requires Akt1, FoxO3a, GSK-3β, and β-catenin to foster vascular integrity during experimental diabetes.

Authors:  Zhao Zhong Chong; Jinling Hou; Yan Chen Shang; Shaohui Wang; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2011-05       Impact factor: 1.990

Review 3.  Translating cell survival and cell longevity into treatment strategies with SIRT1.

Authors:  K Maiese; Z Z Chong; Yan Chen Shang; S Wang
Journal:  Rom J Morphol Embryol       Date:  2011       Impact factor: 1.033

4.  FOXO3a governs early and late apoptotic endothelial programs during elevated glucose through mitochondrial and caspase signaling.

Authors:  Jinling Hou; Zhao Zhong Chong; Yan Chen Shang; Kenneth Maiese
Journal:  Mol Cell Endocrinol       Date:  2010-03-06       Impact factor: 4.102

Review 5.  Insulin resistance in obesity: an overview of fundamental alterations.

Authors:  Rocco Barazzoni; Gianluca Gortan Cappellari; Maurizio Ragni; Enzo Nisoli
Journal:  Eat Weight Disord       Date:  2018-02-03       Impact factor: 4.652

Review 6.  Ghrelin forms in the modulation of energy balance and metabolism.

Authors:  Gianluca Gortan Cappellari; Rocco Barazzoni
Journal:  Eat Weight Disord       Date:  2018-10-24       Impact factor: 4.652

Review 7.  New strategies for Alzheimer's disease and cognitive impairment.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

8.  Chronic renal failure, cachexia, and ghrelin.

Authors:  A Laviano; Z Krznaric; K Sanchez-Lara; I Preziosa; A Cascino; F Rossi Fanelli
Journal:  Int J Pept       Date:  2010-02-04

Review 9.  The vitamin nicotinamide: translating nutrition into clinical care.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Molecules       Date:  2009-09-09       Impact factor: 4.411

Review 10.  Erythropoietin, forkhead proteins, and oxidative injury: biomarkers and biology.

Authors:  Kenneth Maiese; Jinling Hou; Zhao Zhong Chong; Yan Chen Shang
Journal:  ScientificWorldJournal       Date:  2009-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.